Photodynamic therapy for esophageal lesions: selectivity depends on wavelength, power, and light dose.

Autor: van den Boogert J; Laboratory for Experimental Surgery, Erasmus University, Rotterdam, The Netherlands., van Staveren HJ, de Bruin RW, Eikelaar JH, Siersema PD, van Hillegersberg R
Jazyk: angličtina
Zdroj: The Annals of thoracic surgery [Ann Thorac Surg] 1999 Nov; Vol. 68 (5), pp. 1763-9.
DOI: 10.1016/s0003-4975(99)01003-6
Abstrakt: Background: Photodynamic therapy with 5-aminolevulinic acid-induced photosensitization could selectively eliminate esophageal epithelial lesions. This study aimed at optimizing laser parameters for 5-aminolevulinic acid photodynamic therapy of the normal rat esophagus.
Methods: Sixty rats received 200 mg/kg 5-aminolevulinic acid orally and were illuminated 3 hours later with either 633 or 532 nm light (n = 30 for each group) through an endoesophageal balloon catheter. Rats received either 8.3 or 25 J/cm diffuser, applied with a 33, 100, or 300 mW/cm diffuser. During illumination, tissue fluorescence measurements and light dosimetry were done. Rats were sacrificed at 48 hours after photodynamic therapy.
Results: During illumination, protoporphyrin IX fluorescence declined faster when a higher power output was used. Fluence rate at the esophageal surface was highest for 633-nm light. At 532 nm, light caused less damage to the epithelium and muscle than 633-nm light. Illumination with 33 mW resulted in selective epithelial ablation, whereas illumination with 300 mW caused muscle damage with minor epithelial damage.
Conclusions: The assumed selective epithelial damage of 5-aminolevulinic acid photodynamic therapy in the esophagus largely depends on the combination of wavelength, power, and light dose applied. Most selective epithelial damage was found when low-power 633-nm light was used.
Databáze: MEDLINE